Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed in the record history. This appears to be a minor maintenance update to the page history rather than a change to trial details.
    Difference
    0.1%
    Check dated 2026-03-11T20:00:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added site revision v3.4.2 and removed the funding-lapse notice and the previous revision v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:34:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and updated the page revision to v3.4.1; the previous revision v3.4.0 was removed.
    Difference
    0.9%
    Check dated 2026-02-04T00:22:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history page adds UI-related notes like Show glossary and color-coded indicators for additions and deletions, and updates revision labels (e.g., Revision: v3.4.0). These are formatting changes that do not alter core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T23:30:07.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The history now displays Revision: v3.3.3 in the footer. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:44:45.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Version history shows the addition of revision v3.3.2 and the removal of v3.2.0 in the record history for NCT03997539. These changes are administrative and do not alter study content, eligibility criteria, outcomes, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:39:50.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.